Penn’s one-stop solution for technology commercialization and entrepreneurship
I’m a Faculty Member or Researcher
I’m with a Company
I’m an Entrepreneur
I want to:
Translating Discoveries
PCI helps to translate discoveries and ideas created at the University of Pennsylvania into new products and businesses for societal benefit.
We actively facilitate a broad range of technology development connections between Penn and the private sector. Whether the end result is a technology license, an R&D alliance, or the formation of a new venture, PCI serves as a dedicated one-stop shop for commercial partnering with Penn.
Join Us at the Celebration of Innovation

It gives us great pleasure to invite you to the Penn Center of Innovation’s 10th annual Celebration of Innovation on Tuesday, December 2, 2025 where we will celebrate Penn researchers and innovators named as inventors on patents issued to Penn this past fiscal year. During the celebratory program we will also present several special awards for exceptional achievements in technology innovation and commercial translation, including:
- Deal of the Year
- Newcomer of the Year
- Startup of the Year
- The Paul D. Sehnert Partner of the Year
- Inventor of the Year
Networking will begin at 4pm and the program will start between 4:30pm and 4:45pm.
We hope you will be able to join us for the celebration, which will be held this year from 4pm to 6pm in the JMEC Law Library and Auditorium (3400 Civic Center Blvd, Philadelphia, PA 19104) on the 5th floor. Register here.
PCI’s New Technology LinkedIn Page
PCI recently launched a new LinkedIn page showcasing our technologies that are currently available for investment and partnership opportunities. Follow here.
Available Technologies
Find technology opportunities by sector or search:
Nanotechnology | Antibody | Optics & Photonics | Medical Devices | COVID-19 | Immunology | Oncology | Materials | Bioengineering | Neurodegenerative Diseases
View all technologies
Recent News
All NewsPenn Spinout Capstan Therapeutics Acquired by AbbVie for $2.1B
Penn Medicine’s Kiran Musunuru Featured in The New York Times for Gene Therapy Breakthrough
Penn Engineering’s Liang Feng Conducts Promising Research on Nonlinear Neural Networks to Train AI on Lightspeed
New Tools for Treating Advanced Retinal Degenerations Developed by Penn Vet Researchers
Discover CAR T-cell technology at Penn
Our latest CAR T-cell enhancement portfolio features innovations poised to transform treatment efficacy with boosted cytokine activity/metabolism, streamlined manufacturing, and reduced T-cell exhaustion. Join us in turning lab discoveries into real-world impact through licensing opportunities with PCI.
